NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Manhattan Pharmaceuticals, Inc. 

810 Seventh Avenue
4th Floor
New York  New York  10019  U.S.A.
Phone: 212-582-3950 Fax: 212-582-3957


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Manhattan Pharmaceuticals, Inc. (MHA) Provides Corporate Update on Hedrin and Management Restructuring, CEO Steps Down 6/18/2009 7:22:11 AM    More...
Manhattan Pharmaceuticals, Inc. (MHA) Completes $1 Million Financing 11/25/2008 8:43:20 AM    More...
Manhattan Pharmaceuticals, Inc. (MHA) Announces Results of Phase 2a Study of Topical PTH (1-34) for the Treatment of Psoriasis 8/1/2008 9:00:54 AM    More...
Manhattan Pharmaceuticals, Inc. (MHA) Announces Amendment of Joint Venture Deal With Nordic Biotech 6/13/2008 7:00:26 AM    More...
Manhattan Pharmaceuticals, Inc. (MHA) to Present At Rodman & Renshaw 5th Annual Global Healthcare Conference 5/19/2008 10:30:05 AM    More...
Manhattan Pharmaceuticals, Inc. (MHA) Announces Completion of Enrollment in Phase 2a Study of Topical PTH (1-34) for Psoriasis 4/10/2008 10:02:28 AM    More...
Manhattan Pharmaceuticals, Inc. (MHA) to Trade on OTCBB Under New Ticker Symbol MHAN 3/26/2008 9:43:12 AM    More...
Manhattan Pharmaceuticals, Inc. (MHA) Successfully Completes Pre-IND Meetings for Altoderm and Altolyn 3/6/2008 7:23:59 AM    More...
Manhattan Pharmaceuticals, Inc. (MHA) Announces Closing of Joint Venture With Nordic Biotech 2/27/2008 6:22:10 AM    More...
Manhattan Pharmaceuticals, Inc. (MHA) to Voluntarily Withdraw Its AMEX Common Stock Listing 2/25/2008 10:18:42 AM    More...
123456789